@article{TAU20905,
author = {Francesco Soria and Shahrokh F. Shariat},
title = {Biomarkers for the prediction of oncologic outcomes in nonmuscle invasive bladder cancer: state of affairs and new frontiers},
journal = {Translational Andrology and Urology},
volume = {7},
number = {Suppl 6},
year = {2018},
keywords = {},
abstract = {Non-muscle invasive bladder cancer (NMIBC) represents approximately 75% of newly diagnosed bladder cancers (BCa) in western countries (1). Patients with NMIBC have a relatively favorable prognosis, with ten-years cancer-specific survival (CSS) rates varying between 75% and 100%, depending on tumor grade (2).},
issn = {2223-4691}, url = {https://tau.amegroups.org/article/view/20905}
}